Leaflet IASOFLU 2 GBQ/ml solution for injection

Indicated for: diagnostic imaging

Route of administration: injectable

Substance: sodium fluoride (18F) (contrast agent)

ATC: V09IX06 (Various | Tumour detection | Other diagnostic radiopharmaceuticals for tumour detection)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Sodium fluoride (18F) is a radioactive compound used in medical imaging, particularly in positron emission tomography (PET). It is used to detect bone abnormalities, such as bone metastases, by highlighting areas of increased metabolic activity.

The substance is administered intravenously and accumulates in areas of active bone formation, providing detailed images of the skeleton. It is a valuable tool in diagnosing and monitoring cancer and other bone conditions.

Side effects are rare but may include allergic reactions or discomfort at the injection site. As a radioactive compound, its use is strictly controlled and performed only under the supervision of a specialist.

Consult your doctor for detailed information about the procedure and to understand the benefits and risks associated with Sodium fluoride (18F).

General data about IASOFLU 2 GBQ/ml

  • Substance: sodium fluoride (18F)
  • Date of latest medicines list: 01-07-2013
  • Product code: W56708001
  • Concentration: 2 GBq / ml
  • Pharmaceutical form: solution for injection
  • Quantity: 1
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: ARGOS ZYKLOTRON BETRIEBSGESMBH GMBH - AUSTRIA
  • Holder: IASON GMBH - AUSTRIA
  • Number: 8035/2015/01
  • Shelf life: 16h-de la data fabricatiei;10h-de la prima utilizare